MedTrace Logo

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19

NCT04380870 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-09-28

No results posted yet for this study

Summary

The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.

Conditions

  • Coronavirus Infection

Interventions

DIETARY_SUPPLEMENT

Chinese Herbal Medicine

Chinese Herbal Medicine (CHM) has been used in the prevention and treatment of epidemic diseases dating back to the Han, Ming and Qing Dynasties and extending al the way through modern times. CHM formulas may contain plant elements of root, seed, back, stem or leaf in addition to minerals and other natural substances. All herbs dispensed in this trial will be from Spring Wind Herb Company.

Sponsors & Collaborators

Principal Investigators

  • Lisa Taylor-Swanson, PhD · University of Utah

  • Lisa Conboy, DSc · Beth Israel Deaconness Medical Center, Harvard Medical School

Eligibility

Min Age
18 Years
Max Age
114 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2021-12-11
Completion
2025-05-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04380870 on ClinicalTrials.gov